Panelists discuss how current risk stratification systems, particularly the European Leukemia Net 2022 classification for intensive therapy and the 2024 classification for lower intensity treatments, ...
Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102).
Tumor classification systems provide the language that allows teams of physicians and health care workers to communicate clearly about neoplasms, their natural histories, and their likely responses to ...
Correspondence to Dr John E Kuhn, Chief of Shoulder Surgery, Vanderbilt University Medical Center, Vanderbilt Sports Medicine, 3200 MCE South Tower, 1215 21st Avenue South, Nashville, TN 37232, USA; j ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results